Twelve deaths associated with the use of controversial blood thinners Xarelto and Pradaxa have been reported to the medicines regulator during the first six months of this year.
They bring the total number of deaths reported in association with these new drugs to 31 since the start of 2012.
All blood thinners carry the risk of dangerous bleeding, but there have been persistent and lingering concerns about the safety of Pradaxa in particular since its approval in...
Subscribe from just €1 for the first month!
All Digital Access + eReader
Unlimited Access for 1 Month
Then €19.99 a month after the offer period.
€149 For the 1st Year
Unlimited Access for 1 Year
90 Day Pass
Get a Business Account for you and your team